CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,877,065
- in 6 filings, $10.0M under 10b5-1 plans
Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-21 | Savage William Jacob Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −3,000 | 17,326 | ||
| 2023-08-15 | Bitterman Kevin Director | Sale | −72,931 | $52.40 | $3.8M | 882,224 |
| 2023-08-15 | Atlas Venture Fund X, L.P. 10% owner | Sale | −111,069 | $52.40 | $5.8M | 1,951,234 |
| 2023-08-15 | Atlas Venture Fund X, L.P. 10% owner | Sale | −72,931 | $52.40 | $3.8M | 882,224 |
| 2023-08-15 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −3,708 | $52.27 | $194K | 3,964 |
| 2023-08-15 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −2,125 | $53.26 | $113K | 1,839 |
| 2023-08-15 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −1,839 | $53.96 | $99K | 0 |
| 2023-08-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −75,000 | $52.00 | $3.9M | 2,162,303 |
| 2023-08-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −98,000 | $53.00 | $5.2M | 2,064,303 |
| 2023-08-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −2,000 | $54.80 | $110K | 2,062,303 |
| 2023-08-09 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −3,200 | $48.90 | $156K | 12,741 |
| 2023-08-09 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −3,588 | $50.22 | $180K | 9,153 |
| 2023-08-09 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −1,481 | $50.91 | $75K | 7,672 |
| 2023-08-01 | Bryce Joanne Chief Financial Officer | Option exercise 10b5-1 | +4,521 | $1.01 | $5K | 5,781 |
| 2023-08-01 | Bryce Joanne Chief Financial Officer | Sale 10b5-1 | −3,067 | $49.63 | $152K | 2,714 |
| 2023-08-01 | Bryce Joanne Chief Financial Officer | Sale 10b5-1 | −1,454 | $50.50 | $73K | 1,260 |
| 2023-08-01 | Bryce Joanne Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,521 | 1,507 | ||
| 2023-06-30 | MacDonald Brian Richard Chief Innovation Officer | Sale 10b5-1 | −2,923 | $44.85 | $131K | 14,277 |
| 2023-06-30 | MacDonald Brian Richard Chief Innovation Officer | Sale 10b5-1 | −1,401 | $45.45 | $64K | 12,876 |
| 2023-06-30 | MacDonald Brian Richard Chief Innovation Officer | Sale 10b5-1 | +600 | $46.76 | $28K | 12,276 |
Page 29 of 32 · 639 trades